NeuroOne CFO granted options on 35,000 shares

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) reported that Chief Financial Officer Christopher Volker received a grant of options to purchase 35,000 shares of common stock.

Rhea-AI Filing Summary

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) reported that Chief Financial Officer Christopher Volker received a grant of options to purchase 35,000 shares of common stock. The options have an exercise price of $1.77 per share and expire on August 27, 2036. According to the vesting terms, 25% of the options will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments thereafter. Following this award, Volker holds 35,000 option shares directly from this grant.

Insider Trade Summary

Grant/Award: 35,000 shares

Grant/Award 1 txn

Insider Volker Christopher

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Option to Purchase Common Stock F1	35,000	$0.00	$0.00

Holdings After Transaction: Option to Purchase Common Stock — 35,000 contracts (Direct)

Footnotes (1)

1. F1. 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

Key Figures

Option shares granted: 35,000 shares Exercise price: $1.77 per share Options held after grant: 35,000 shares +4 more

7 metrics

Option shares granted 35,000 shares Option to Purchase Common Stock granted to CFO on 2026-08-28

Exercise price $1.77 per share Conversion or exercise price of the option grant

Options held after grant 35,000 shares Total option shares following this reported transaction

Option expiration date 2036-08-27 Expiration date of the option to purchase common stock

Initial vesting tranche 25% Vests on August 28, 2027

Remaining vesting portion 75% Vests in 12 equal quarterly installments after August 28, 2027

Quarterly installments 12 installments Number of equal quarterly vesting tranches for remaining options

Key Terms

Option to Purchase Common Stock, exercise price, vesting, quarterly installments

4 terms

Option to Purchase Common Stock financial

"security_title: "Option to Purchase Common Stock""

exercise price financial

"conversion_or_exercise_price: "1.7700""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"25% will vest on August 28, 2027, and the remaining 75% will vest"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

quarterly installments financial

"the remaining 75% will vest in 12 equal quarterly installments"

FAQ

What did NMTC disclose about Christopher Volker’s new option grant?

NMTC disclosed that Christopher Volker received an option to purchase 35,000 shares of common stock at an exercise price of $1.77 per share, expiring on August 27, 2036, with time-based vesting starting in 2027.

What is the exercise price of the new NMTC stock options granted to the CFO?

The options granted to the NMTC Chief Financial Officer have an exercise price of $1.77 per share, as reported in the Form 4 filing for the 35,000-share option award.

How do the NMTC options granted to the CFO vest over time?

For the NMTC option grant, 25% of the options vest on August 28, 2027. The remaining 75% vest in 12 equal quarterly installments after that initial vesting date, subject to continued service.

When do the NMTC stock options granted to Christopher Volker expire?

The NMTC options granted to Christopher Volker expire on August 27, 2036, giving a 10-year term from the August 28, 2026 grant date reported in the Form 4.

How many NMTC option shares does the CFO hold from this grant after the transaction?

Following this reported transaction, the NMTC Chief Financial Officer holds 35,000 option shares directly from this specific option grant, as indicated by the total shares following the transaction field.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 05:05 PM Accepted by SEC EDGAR 08/28/2026 - 05:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Volker Christopher

(Last) (First) (Middle)

7599 ANAGRAM DR.

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NEUROONE MEDICAL TECHNOLOGIES Corp [ NMTC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$1.77	08/28/2026		A		35,000		(1)	08/27/2036	Common Stock	35,000	$0	35,000	D

Explanation of Responses:

1. 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

	/s/ Emily Johns, by Power of Attorney	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)